x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

CANCER BUZZ

Association of Cancer Care Centers

CANCER BUZZ features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

science

All Episodes

06:15

Developing a Health Equity Playbook

CANCER BUZZ ·

2024/09/26

Designing a health equity playbook starts with a deep understanding of the patients you serve. Successful playbooks have components that build on the patient experience, the protocols that are in place to ensure the cancer program is meeting the unique needs of all its patients, and staff education and and training on how to best serve those different patient populations. When developing a health equity playbook, cancer programs need to break down existing silos and ensure that all key players are

en

08:21

Shared Decision Making in Relapsed/Refractory Mantle...

CANCER BUZZ ·

2024/09/24

The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical College of Wisconsin and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC, assistant professor of pharmacy at

en

19:30

Psychosocial Support in Head and Neck Cancer Care

CANCER BUZZ ·

2024/09/12

Advancements in treatment combined with a multimodal approach are improving outcomes for patients with head and neck cancer. However, the unique challenges of a head and neck cancer diagnosis and its treatment side effects—such as speech and communication difficulties as well as negative effects on body image and self-esteem—can significantly impact a patient’s mental health. In this episode, CANCER BUZZ speaks with Jacquelyn Doenges, LCSW, MSSW, CTTS, clinical oncology social worker at UT

en

05:42

Addressing Sexual Health in Oncology Patients

CANCER BUZZ ·

2024/08/29

Female sexual dysfunction is a well-studied adverse effect of cancer treatment. Despite its prevalence, however, it remains vastly underdiagnosed and undertreated in oncology patients, with providers inadequately addressing sexual function before, during, and after treatment. Although most patients prefer that their providers initiate conversations regarding sexual health, providers may be reticent to screen for such problems due to insufficient knowledge and expertise in the diagnosis and

en

12:10

Care Coordination for Advanced Non-Melanoma Skin Cancers

CANCER BUZZ ·

2024/08/22

Effective partnerships between dermatologists and oncologists are an essential component of care coordination for patients with advanced non-melanoma skin cancers. This interprofessional collaboration can be more challenging in the community setting, where fewer resources are available in comparison to large academic medical centers. In this podcast episode, CANCER BUZZ speaks with Emily Smith, MD, associate professor of Dermatology at St. Louis University School of Medicine, about best practices

en

06:29

A Practice Within a Practice: Integrating...

CANCER BUZZ ·

2024/08/15

Novel cancer therapies have emerged over the past 10-15 years with high rates of cutaneous side effects, leading to increased demand for specialists in oncodermatology. These subspecialists have expertise in managing therapeutic complications, cutaneous metastases, and proactive management of potential adverse events. In this episode, CANCER BUZZ TV speaks with guest Meghan Heberton, MD, director of Oncodermatology and assistant professor of Dermatology at UT Southwestern Medical Center – Harold C

en

06:49

Adverse Event Management in Relapsed/Refractory...

CANCER BUZZ ·

2024/08/08

Common adverse events associated with treatment of mantle cell lymphoma include gastrointestinal, hematologic, and cardiac toxicities. Proactive management of these toxicities and collaboration between members of the cancer care team, including pharmacists, are key to optimizing patient outcomes. In this episode, CANCER BUZZ speaks with Karen Fancher, PharmD, BCOP, clinical pharmacy specialist in oncology at University of Pittsburgh – Passavant Hospital, and Victoria Nachar, PharmD, BCOP, clinical

en

06:52

How Do I Say It? Patient-Provider Communication in...

CANCER BUZZ ·

2024/07/30

Effective communication between patients and healthcare providers is crucial to facilitate shared decision-making and meaningful dialogue that supports improved patient outcomes in diffuse large B-cell lymphoma (DLBCL) care. In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, Georgia, about fostering trust, rapport, and collaboration in the patient-provider

en

07:05

Addressing Frequency of Care to Improve Quality of...

CANCER BUZZ ·

2024/07/25

Anemia presents a significant challenge in the management of patients with low-risk myelodysplastic syndromes (MDS). Given the considerable potential for symptom burden associated with anemia in patients with MDS, health care professionals must prioritize enhancing quality of life when evaluating treatment options. In this episode, CANCER BUZZ speaks with David Sallman, MD, associate member in the Department of Malignant Hematology at Moffitt Cancer Center, and Karley Trautman, DNP, ANP-BC,

en

04:25

Creating a Community-Wide Safety Net for Centralized...

CANCER BUZZ ·

2024/07/23

Enterprise intelligence software analyzes imaging results of all patients treated at UCHealth to identify and stratify those with high-risk findings. When a concerning abnormality is found, patients and providers are alerted to the finding, and patients are referred for additional follow-up. After this system-wide approach led to a 2,514% increase in actively managed patients, a centralized care management function was implemented to streamline processes, reducing the time to recommend next steps

en

05:07

Empowering Laboratory Professionals to Optimize...

CANCER BUZZ ·

2024/07/18

New opportunities are emerging for dedicated biomarker testing navigators facilitated by laboratory professionals to better streamline sample collection and optimize test ordering and results for patients with cancer. In this episode, CANCER BUZZ TV speaks with Lynnette Pineault, MBA, SCT (ASCP), chair of the American Society for Clinical Pathology (ASCP) Biomarker Testing Navigation Feasibility Study and manager of Laboratory Operations and Genetic Counseling Services, Medical Library and Pathology

en

04:30

A One-Stop Breast Clinic Improves Time to Diagnosis...

CANCER BUZZ ·

2024/07/16

This accelerated delivery platform improves clinic workflow and speeds up breast cancer diagnosis and treatment planning. From screening mammogram, a clinical pathway flags patients who meet One-Stop Breast Clinic criteria, eliminating the traditional “first come, first served” scheduling model. To date, more than 300 patients have benefited from this rapid diagnostic approach, receiving their diagnosis in 3 to 7 days, far below the national average of 26 days. Guest: Michele Brands Network Director

en

09:13

Defining and Managing Erythropoietin Stimulating...

CANCER BUZZ ·

2024/07/11

Anemia presents a significant challenge in the management of patients with low-risk myelodysplastic syndromes (MDS). As clinicians focus on maintaining quality of life, it is necessary to understand the care sequencing of anemia treatment in patients with low-risk MDS. In this episode, CANCER BUZZ speaks with Steven Gilmore, PharmD, BCOP, Senior Manager of Clinical Content in Pharmacy and Clinical Programs with McKesson Specialty Health, and Christopher Benton, MD, hematologist and medical

en

06:08

A Sustainable Model for Improved Quality for...

CANCER BUZZ ·

2024/07/09

This AI-driven incidental findings program identifies and then monitors pancreatic abnormalities to improve the quality of care to patients who are at increased risk for developing pancreatic cancer. To do so, the patient management software integrates with the electronic health record and facilitates patient identification, risk assessment, care plan tracking, patient and provider communication, outcomes recording, and registry functionality. In the 2 years following program implementation, 82

en

04:58

Smart-Texting High-Risk Patients After Chemotherapy...

CANCER BUZZ ·

2024/07/02

This machine learning algorithm runs nightly and is linked to a smart texting application that goes out to patients every morning for 7 days following chemotherapy, asking about symptoms like diarrhea, fever, nausea, vomiting, and pain. Patients reporting severe or worsening symptoms have the smart text escalated to the oncology clinic where they received chemotherapy. Initial analysis broken down by responders (those that opted in and answered the daily text messages) and non-responders (opted out

en

05:59

Promoting Equitable Care through the 4R Oncology® Model

CANCER BUZZ ·

2024/06/27

While molecularly targeted therapies based on actionable biomarkers are improving outcomes for patients with lung cancer, access to biomarker testing continues to hinder equitable and comprehensive care for underserved patients. In this episode, CANCER BUZZ TV speaks with Tom Lycan, DO, MHS, assistant professor of Hematology & Oncology at the Wake Forest School of Medicine, about a practical tool that can provide a care plan roadmap for providers and patients to mitigate precision medicine

en

05:07

Implementation of a Bispecific T-Cell Engager Therapy...

CANCER BUZZ ·

2024/06/25

Development of this comprehensive bispecific antibody program included policy development; toxicity management; creation of patient and staff education documents; creation of clinician tools like a toxicity scoring and charting tool and an electronic order set that segregates treatment options; and a monitoring system to safely transition patients from inpatient to outpatient care. Guest: Courtney VanHouzen, PharmD PGY-2 Oncology Resident Munson Healthcare, Cowell Family Cancer Center Traverse City,

en

05:39

Leveraging the EHR to Automate Biosimilar Selection...

CANCER BUZZ ·

2024/06/18

This rule-based informatics solution pulls from the electronic health record to automate the election of an appropriate biosimilar therapy based on the patient’s insurance and hospital formulary preferences, streamlining prior authorization and approval processes. This e-tool decreased administrative burden to providers, pharmacists, and prior authorization specialists and increased biosimilar utilization by 21.9%. Guest: Sarah Hudson-DiSalle, PharmD, RPh, FACCC Assistant Director of Reimbursement

en

07:39

Community CAR T-Cell Patient Identification Framework

CANCER BUZZ ·

2024/06/11

As the use of chimeric antigen receptor (CAR) T-cell therapy continues to expand as an effective treatment for hematologic malignancies, understanding how to identify eligible patients early and implementation of an effective framework for identification can improve care coordination and better prepare community cancer programs for widespread use of CAR T-cell therapy. In this episode, CANCER BUZZ speaks with David L. Porter, MD, director of Cell Therapy and Transplant at Penn Medicine, about the

en

05:20

Social Determinants of Health in Metastatic Breast...

CANCER BUZZ ·

2024/05/30

Social determinants of health have been proven to impact access to care, but further delineation is necessary to describe their effect on treatment selection itself. To mitigate this knowledge gap, the Association of Cancer Care Centers (ACCC) sought to identify the impact that social determinants of health may have on guideline-concordant treatment selection in hormone receptor positive, HER2 negative, metastatic breast cancer and early breast cancer. In this episode, CANCER BUZZ speaks with

en

318 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter